OKYO Pharma (OKYO) Earnings Analysis

OKYO Pharma (OKYO) next reports earnings on 2026-08-10. Last quarter (2026-07-20) it missed with EPS -0.15 USD vs -0.08 USD est (-87.5%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E -13.91.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does OKYO next report earnings?

Next earnings date2026-08-10
Consensus EPS estimaten/a
Revenue estimaten/a

OKYO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-07-20-0.15 USD-0.08 USD-87.5%Miss
2026-01-30-0.01 USD-0.07 USD+85.7%Beat
2025-01-29-0.08 USDn/an/an/a

Beat rate: 1/2 (50%) over reported quarters with consensus data.

OKYO valuation and analyst view

Trailing P/E-13.91
Trailing EPS-0.12328 USD
Price / book4.61
Dividend yield0.00%
Market cap0.06B
Analyst consensusBuy (2 buy / 0 hold / 0 sell)
Avg price target5 USD

Related research pages

Frequently asked questions

When is OKYO Pharma (OKYO)'s next earnings date?

OKYO Pharma is next scheduled to report on 2026-08-10.

Did OKYO beat earnings last quarter?

In its 2026-07-20 report, OKYO posted EPS of -0.15 USD versus a -0.08 USD estimate — a miss of 87.5%.

What is OKYO's earnings track record?

Over the last 2 reported quarters with consensus data, OKYO beat estimates 1 times (50%).

What is OKYO's current P/E ratio and EPS?

OKYO trades at a trailing P/E of -13.91 on trailing EPS of -0.12328106046904588 USD.

What do analysts rate OKYO?

Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 5 USD.